Peled N, Gillis R, Kilickap S, Froesch P, Orlov S, Filippova E, Demirci U, Christopoulos P, Cicin I, Basal FB, Yilmaz C, Fedor M, Korkmaz T, Paydas S, Gautschi O, Zirtiloglu A, Eralp Y, Cinkir HY, Sezer A, Erman M, Tural D, Turna H, Mazieres J, Dudnik E, Reguart N, Camidge DR, Ng TL, Senler F?, Beypinar I, Yazilitas D, Demirkazik A, Karaoglu A, Okutur K, Coskun HS, Sendur MAN, Isikdogan A, Cabuk D, Yumuk PF, Yildiz I, Kaplan MA, ?zyilkan ?, ?ztop I, Olmez OF, Aydin K, Aydiner A, Meydan N, Grinberg RD, Roisman LC. GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients. Lung Cancer. 2020 10; 148:48-54.